miR-143-5p suppresses breast cancer progression by targeting the HIF-1α-related GLUT1 pathway

被引:17
|
作者
Xu, Jia [1 ]
Li, Xi [2 ]
Zhang, Purong [1 ]
Luo, Jie [1 ]
Mou, Exian [1 ]
Liu, Shiwei [1 ]
机构
[1] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med,Dept Breast Surg, 55,Sect 4,South Renmin Rd, Chengdu 610041, Sichuan, Peoples R China
[2] Chengdu First Peoples Hosp, Dept Plast Surg, Chengdu 610041, Sichuan, Peoples R China
关键词
breast cancer; microRNA-143-5p; hypoxia-inducible factor-1 alpha; glucose transporter 1; migration; RADIATION-THERAPY; GENE-EXPRESSION; GASTRIC-CANCER; MICRORNAS; METASTASIS; INVASION; IDENTIFICATION; STATISTICS; METABOLISM; PROGNOSIS;
D O I
10.3892/ol.2022.13268
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer (BC) is a commonly identified life-threatening type of cancer and a major cause of death among women worldwide. Several microRNAs (miRs), including miR-143-5p, have been reported to be vital for regulating hallmarks of cancer; however, the effect of miR-143-5p on BC requires further exploration. The present study performed bioinformatics analysis on GSE42072 and GSE41922 datasets from the National Center for Biotechnology Information Gene Expression Omnibus (GEO) database to identify miR-143-5p expression patterns. Furthermore, miR-143-5p expression was detected in BC cell lines and tissues via reverse transcription-quantitative PCR. Post-transfection with miR-143-5p mimics, Cell Counting Kit-8, colony formation and Transwell assays were performed to explore the effects of miR-143-5p on BC cell proliferation, colony formation, and migration. The association of miR-143-5p with the hypoxia-inducible factor-1 alpha (HIF-1 alpha)-associated glucose transporter 1 (GLUT1) pathway was explored via western blotting, immunofluorescence and dual-luciferase reporter assay. The present study detected high expression of miR-143-5p in BC tissue of the GSE42072 and serum of the GSE41922 datasets by GEO chip analysis. Additionally, the expression levels of miR-143-5p were decreased in BC tissues compared with those in adjacent healthy tissues, and low miR-143-5p expression was associated with a poorer prognosis and shorter survival time in patients with BC. In vitro, miR-143-5p expression levels were decreased in BC cells, and transfection with miR-143-5p mimics suppressed BC cell proliferation, colony formation, migration. Furthermore, miR-143-5p targeted the HIF-1 alpha-related GLUT1 pathway, and inhibited HIF-1 alpha and GLUT1 expression. Additionally, HIF-1 alpha agonists reversed the miR-143-5p-induced inhibition during tumorigenesis. In conclusion, miR-143-5p exhibited low expression in BC tissues, and suppressed BC cell proliferation, colony formation, migration. Moreover, the antitumor effects of miR-143-5p targeted the HIF-1 alpha-related GLUT1 pathway.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Targeting TRMT5 suppresses hepatocellular carcinoma progression via inhibiting the HIF-1α pathways
    Zhao, Qiong
    Zhang, Luwen
    He, Qiufen
    Chang, Hui
    Wang, Zhiqiang
    Cao, Hongcui
    Zhou, Ying
    Pan, Ruolang
    Chen, Ye
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2023, 24 (01): : 50 - 63
  • [22] miR-455-5p suppresses hepatocellular carcinoma cell growth and invasion via IGF-1R/AKT/GLUT1 pathway by targeting IGF-1R
    Hu, Yiren
    Yang, Zhangwei
    Bao, Dandan
    Ni, Jun-Sheng
    Lou, Jian
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (12)
  • [23] Analysis of miRNA-mRNA network reveals miR-140-5p as a suppressor of breast cancer glycolysis via targeting GLUT1
    He, Yunjie
    Deng, Fei
    Zhao, Shujie
    Zhong, Shanliang
    Zhao, Jianhua
    Wang, Dandan
    Chen, Xiu
    Zhang, Tian
    Hou, Junchen
    Zhang, Wei
    Ding, Li
    Tang, Jinhai
    Zhou, Zuomin
    EPIGENOMICS, 2019, 11 (09) : 1021 - 1036
  • [24] P4HA1 is a new regulator of the HIF-1 pathway in breast cancer
    Xu, Ren
    CELL STRESS, 2019, 3 (01) : 27 - 28
  • [25] Targeting HIF-1α signaling pathway for gastric cancer treatment
    Li, Hongyu
    Jia, Yanfei
    Wang, Yunshan
    PHARMAZIE, 2019, 74 (01): : 3 - 7
  • [26] Hypoxia-responsive miR-141-3p is involved in the progression of breast cancer via mediating the HMGB1/HIF-1α signaling pathway
    Sun, Shanping
    Ma, Jinglin
    Xie, Panpan
    Wu, Zhen
    Tian, Xingsong
    JOURNAL OF GENE MEDICINE, 2020, 22 (10):
  • [27] MKLN1-AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF-1α through miR-185-5p/TEAD1 pathway
    Chen, Jiayu
    Li, Lei
    Feng, Yongpu
    Zhao, Yating
    Sun, Fengyuan
    Zhou, Xianzhu
    Yiqi, Du
    Li, Zhaoshen
    Kong, Fanyang
    Kong, Xiangyu
    CELL BIOLOGY AND TOXICOLOGY, 2024, 40 (01)
  • [28] MiR-939-5p suppresses PM2.5-induced endothelial injury via targeting HIF-1α in HAECs
    Liang, Shuang
    Ning, Ruihong
    Zhang, Jingyi
    Liu, Jiangyan
    Zhang, Jie
    Shen, Heqing
    Chen, Rui
    Duan, Junchao
    Sun, Zhiwei
    NANOTOXICOLOGY, 2021, 15 (05) : 706 - 720
  • [29] HIF-1α Regulates the Progression of Cervical Cancer by Targeting YAP/TAZ
    Abudoukerimu, Azierguli
    Hasimu, Axiangu
    Abudoukerimu, Abudouhabaer
    Tuerxuntuoheti, Gulijiannaiti
    Huang, Yixin
    Wei, Jie
    Yu, Tao
    Ma, Hong
    Yimiti, Delixiati
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [30] Down regulation of miR-148a is related to enhanced pancreatic cancer pathogenesis through targeting GLUT1
    Wu, Linshi
    Qiu, Weiqing
    Sun, Jianhua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (10): : 4950 - 4956